Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 70%
filed 2026-05-27
Item 2.03
Molson Coors issued $1.5 billion in U.S. senior notes and C$500 million in Canadian senior notes on May 27, 2026, pursuant to supplemental indenture agreements, creating approximately $1.846 billion in aggregate direct financial obligations. The offering consisted of 2031 and 2036 U.S. notes at 4.900% and 5.500% rates, plus Canadian notes at 4.300%, representing a material debt financing transaction affecting the company's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 1.02
The filing discloses termination of two material definitive agreements: (1) the Gemma Collaboration Agreement involving research and license rights for Huntington's disease and Temporal Lobe Epilepsy programs, and (2) the 2005 Market Street Lease Agreement with a $2.3 million termination fee. While Item 1.02 is titled "Termination of a Material Definitive Agreement," neither termination fits cleanly into the specific event taxonomy (not M&A, not covenant breach, not litigation). The Gemma termination is particularly material as it affects active R&D programs in CNS indications, and the lease termination involves a significant cash outlay. This is best classified as other_material given the absence of a more specific category for strategic collaboration or lease terminations.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
TTEC Holdings completed a re-domestication from Delaware to Texas on May 22, 2026, changing its state of incorporation and governing law. The company disclosed that the re-domestication did not materially affect business operations, assets, liabilities, or material contracts.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-05-27
Item 3.03
Item 3.03 discloses a material modification to security holder rights in connection with the merger transaction and related corporate restructuring, incorporating references to the acquisition completion, delisting, change of control, and amendments to articles and bylaws.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 2.02
The filing discloses a dividend announcement under Item 2.02 (Results of Operations and Financial Condition), but the prose does not describe earnings results, financial performance, or operational metrics. A dividend announcement is material to investors as it signals capital allocation and financial health, but it does not fit the earnings_release category (which typically covers quarterly/annual financial results). This is best classified as other_material since it is a material capital allocation event that falls outside the more specific taxonomy categories.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
BridgeBio announced FDA acceptance and priority review of an NDA for BBP-418, a significant regulatory milestone for a drug candidate. While this is a material event affecting investor assessment of the company's pipeline progress and regulatory prospects, it does not fit neatly into the more specific event categories (it is neither an earnings release, executive change, M&A activity, nor a negative event like impairment or litigation). This is best classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
PBF Energy announced a $500 million private offering of senior unsecured notes due 2034 by its subsidiaries. While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, it does not fit cleanly into the dilutive_issuance category (which focuses on equity securities) or other specific event types. This is a material financing event disclosed under Item 8.01 that warrants classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
The company determined Net Asset Value per share across multiple share classes as of April 30, 2026, and declared distributions payable to shareholders, material to investors assessing share pricing and shareholder returns.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 7.01
This Item 7.01 disclosure centers on an Investor Day presentation where TTM Technologies reiterates fiscal 2026 guidance ($4.0B revenue, 13-15% non-GAAP operating margin, 16-18% Adjusted EBITDA margin) and announces material refinancing activity: a $400M repriced Term Loan (reducing borrowing costs by 50 bps) and a new $1B Revolving Credit facility to replace existing ABL facilities, both expected to close in June 2026. While the guidance update resembles forward-looking statements and the refinancing involves debt restructuring, the disclosure does not fit cleanly into earnings_release (no actual results), ma_activity (no acquisition/disposition), or covenant_breach (no violation). The refinancing is material to investors assessing capital structure and financial flexibility, but the Item 7.01 format and forward-looking nature (subject to closing conditions) place it outside the more specific event categories.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 7.01
The company announced initiation of a strategic alternatives review on May 27, 2026, signaling potential material corporate action such as a merger, sale, or restructuring, though the specific nature and outcome of alternatives being considered were not disclosed.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 1.01
American Tower completed a registered public offering of €750 million in senior unsecured notes due 2033, generating approximately $866.7 million in net proceeds. This significant debt issuance affects the company's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 8.01
The Company disclosed its NAV per share as of April 30, 2026 ($19.21), total investments of $1.9 billion, and a debt-to-equity ratio of 0.82x, providing investors with key financial metrics and portfolio composition data.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 2.03
The filing discloses issuance of $90 million in First Mortgage Bonds ($35M at 5.91% due 2036 and $55M at 6.65% due 2056) pursuant to Item 2.03. While this creates a direct financial obligation, it is a routine debt issuance by a utility company rather than a covenant breach, going-concern issue, or other acute financial stress signal. The bonds were issued to institutional investors in reliance on Section 4(a)(2) exemption and are secured by the company's mortgage. This is material to investors but does not fit the more specific event categories (covenant_breach, going_concern, bankruptcy_filing, etc.) and is best classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 7.01
The Company retracted a press release announcing entry into a credit facility for its credit card program and clarified that no such facility has been entered into. This is a material correction of a prior public statement that could have affected investor expectations about the Company's financing and operational capacity. While the retraction itself is a corrective disclosure rather than a new material event, the fact that a material misstatement was publicly issued and then retracted warrants disclosure as a material event affecting the total mix of information available to investors.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 8.01
The Fund reported NAV per share of $22.39 as of April 30, 2026, aggregate NAV of $4.4 billion, portfolio fair value of $7.0 billion, and debt-to-equity leverage of 0.63x, while updating the status of ongoing public and private share offerings totaling approximately $4.8 billion in consideration to date.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 8.01
The filing discloses issuance of $1.375 billion in Series 2026-A Senior Secured SAC Bonds by Appalachian Power Recovery Funding LLC on May 27, 2026, pursuant to an Indenture and Series Supplement. While this is a material debt issuance that would affect investor assessment of the registrant's capital structure and financial obligations, it does not fit cleanly into the M&A activity category (which focuses on acquisitions, dispositions, mergers, or changes of control) and is disclosed under Item 8.01 (Other Events) rather than Item 1.01 or 2.01. The event is material but lacks a more specific taxonomy match.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 7.01
The fund disclosed routine portfolio and distribution information, including a declared distribution of $0.1227 per unit, portfolio composition across 306 companies totaling $7.183 billion in par value, and estimated NAV of $3.25 billion as of April 30, 2026. This periodic Regulation FD disclosure provides material information to unitholders regarding fund performance and income.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 8.01
The company issued $50 million in Tranche C Notes (5.97% due May 22, 2029) on May 22, 2026, and concurrently repaid $111.6 million of existing 5.00% unsecured notes. This debt refinancing activity is material to investors assessing the company's capital structure and leverage.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 7.01
The fund disclosed routine portfolio and distribution information as of April 30, 2026, including a declared distribution of $0.1406 per unit, portfolio composition across 185 companies, estimated net asset value of $311.8 million, and leverage metrics showing debt of $313.1 million against NAV of $311.8 million. While primarily administrative, the leverage and NAV metrics may be material to investors assessing fund performance.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 8.01
The Board approved an extension of the share repurchase program through July 2027 with authorization for up to $242.5 million in repurchases, representing a material commitment of corporate resources and capital deployment strategy.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
Minerva announced a material modification to the Phase 3 C19 trial design for roluperidone, extending the relapse assessment phase from 40 weeks to 52 weeks following FDA feedback, which extends the expected timeline for relapse data delivery to H2 2028.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 7.01
The company disclosed material portfolio and financial updates including a declared distribution of $0.1389 per unit, portfolio composition across 145 companies with $664.1M par value, estimated NAV of $242.3M, and debt outstanding of $307.7M as of April 30, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
JPMorgan Chase announced the redemption of 2,000,000 depositary shares representing Series KK Preferred Stock on June 1, 2026. While this is a material capital structure event affecting preferred shareholders, it does not fit neatly into the more specific event categories (it is not M&A, a covenant breach, dilutive issuance, or other defined types). The redemption is material to investors as it affects the composition of outstanding securities and preferred equity, but the disclosure is primarily administrative in nature—an exercise of optional redemption rights under existing governing documents.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 8.01
Kennametal announced a cash tender offer to repurchase its 4.625% Senior Notes due 2028, with pricing and final results disclosed on May 26, 2026. This represents a material debt management activity affecting the company's capital structure and financial obligations, but does not fit neatly into the more specific event categories (ma_activity applies to acquisitions/dispositions of business units, not debt repurchases). The tender offer is material to investors as it affects leverage and cash position.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 8.01
National Fuel Gas Company disclosed the exercise of optional redemption rights for $300 million in 5.50% Notes due October 2026, with a redemption date of June 11, 2026. While this is a material debt management action affecting the company's capital structure and liquidity, it does not fit cleanly into the specific event categories (not a covenant breach, not a going-concern issue, not a restatement). The redemption is a routine but material corporate finance event that a reasonable investor would want to know about.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
Item 8.01
Hoth Therapeutics, Inc. changed its corporate name to Rocket One Inc. and its ticker symbol from HOTH to RKTO, effective May 27, 2026. The company also formed and renamed a wholly-owned subsidiary from Rocket One Inc. to Rocket One.0 Inc. as part of the corporate restructuring.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 5.03
The Board unanimously adopted Second Amended and Restated Bylaws on May 25, 2026, removing a provision that previously allowed unauthorized or defective transactions to be cured through Board or stockholder approval, materially affecting stockholder derivative suit protections and corporate liability exposure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
This disclosure reports the consummation of an IPO generating $75 million in gross proceeds and a concurrent private placement of $3 million, with trust account establishment. While IPO completion is material to investors, the filing does not fit cleanly into the standard taxonomy categories—it is neither a traditional earnings release, M&A activity, nor a dilutive issuance (which typically refers to unregistered secondary offerings). The event is material but best classified as other_material given the specialized nature of SPAC IPO completion and trust account mechanics.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 5.03
The filing discloses an amendment to the Certificate of Designation increasing authorized Series B Cumulative Convertible Preferred Stock from 397,222 to 572,222 shares (a 44% increase). While this is a structural/governance change disclosed under Item 5.03, the material substance is an expansion of convertible preferred equity capacity, which could signal dilution risk or capital-raising activity. This does not fit neatly into the more specific categories (it is not a dilutive issuance itself, nor a routine bylaw amendment), so other_material is most appropriate.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 5.03
The filing discloses stockholder approval of an Amended and Restated Certificate of Incorporation that effects board declassification and eliminates supermajority voting requirements, along with corresponding bylaw amendments. While Item 5.03 covers amendments to articles and bylaws, these governance changes are material to investors as they fundamentally alter board composition mechanics and voting thresholds, affecting shareholder rights and corporate control dynamics. This does not fit neatly into the more specific event categories (e.g., it is not an executive appointment, departure, or compensation matter), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 2.03
This disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. While Item 2.03 typically captures covenant breaches or material debt arrangements, this filing describes routine debt issuance activity that is material to the Bank's operations but does not fit cleanly into the covenant_breach category (no breach or default is disclosed). The Bank explicitly states "consolidated obligations issuance is material to the Bank," and Schedule A details committed issuances, making this a material event that warrants disclosure but falls outside the more specific event-type categories.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes totaling approximately $560 million across five separate issuances with varying maturities (2026–2034) and coupon rates (3.83%–5.08%). While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing describes routine debt issuance by a Federal Home Loan Bank in the ordinary course of business—a material financing activity that does not fit the specific covenant_breach taxonomy (which implies a triggering default or acceleration). The disclosure is material to investors assessing the registrant's capital structure and funding activities, but the event itself is a standard debt offering rather than a breach or distress signal.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 2.03
This Item 2.03 disclosure reports the issuance of consolidated obligation bonds totaling approximately $390 million across three debt securities (trade dates 5/20–5/22/2026, maturing 2027–12/2027). While the filing explicitly states "consolidated obligations issuance is material to the Bank," the event does not fit cleanly into the standard taxonomy: it is neither a covenant breach (no default triggered), nor a dilutive equity issuance, nor a restatement or going-concern disclosure. The creation of direct financial obligations through routine debt issuance by a Federal Home Loan Bank is material to investors but represents ordinary course funding activity rather than an extraordinary event, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 74%
filed 2026-05-27
Item 8.01
Tonix Pharmaceuticals announced publication of a peer-reviewed Phase 1 clinical trial manuscript for TNX-1500 in the Journal of Clinical Immunology, demonstrating positive immunosuppressive efficacy in blocking T cell-dependent antibody responses at all tested doses. This clinical development milestone is material to investors assessing the company's pipeline progress and de-risking of the lead drug candidate.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-27
bioAffinity Technologies disclosed receipt of a patent allowance notification from the Mexican Institute of Industrial Property for a method related to lung cancer prediction using flow cytometry. While this is a positive intellectual property development, it does not fit cleanly into the standard 8-K event taxonomy (not earnings, M&A, executive changes, impairments, litigation, or cybersecurity). Patent allowances can be material to biotech/diagnostic companies' competitive positioning and valuation, warranting disclosure under Item 8.01 (Other Events).
View raw filing on EDGAR →
8-K
Other material
confidence 74%
filed 2026-05-27
Item 8.01
NextNav announced an election to redeem all outstanding public warrants at $0.01 per warrant with a June 26, 2026 redemption date. This material capital structure event affects warrant holders' rights and the company's equity structure, disclosed via press release and other events notice.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
Murphy USA disclosed the issuance of $500 million in 5.875% Senior Notes due 2034 under Item 8.01 (Other Events). While this is a material debt financing event that would affect investor assessment of the company's capital structure and financial obligations, it does not fit cleanly into the more specific event categories (e.g., it is not a restatement, covenant breach, or going-concern disclosure). The issuance of material debt is a significant corporate event, but the 8-K taxonomy lacks a dedicated "debt_issuance" category, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-27
Item 8.01
Precision Biosciences disclosed late-breaking clinical data from its Phase 1 ELIMINATE-B trial presented at EASL Congress 2026, including new biopsy data demonstrating cccDNA elimination in PBGENE-HBV, establishment of pgRNA as a biomarker, and updated safety profile information. The data directly impacts investor assessment of the company's lead therapeutic candidate and pipeline viability.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 1.01
The Company entered into Extension No. 7 to a convertible promissory note with GHS Investments LLC on May 21, 2026, extending the maturity date from April 29, 2026 to October 31, 2026 and waiving all prior Events of Default. While this is disclosed under Item 1.01 (Material Definitive Agreement), it is fundamentally a debt extension and waiver of defaults rather than entry into a new material acquisition, disposition, merger, or change of control. The repeated extensions and waiver of defaults suggest financial stress, making this material to investors, but it does not fit cleanly into the ma_activity category which contemplates M&A transactions.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 7.01
The Board declared a cash dividend of $0.14 per share on Class I Common Stock, payable June 26, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 8.01
The Company disclosed its net asset value per share of $18.39 for Class I Common Stock as of April 30, 2026 and aggregate NAV of $1.7 billion as of May 26, 2026, along with a status update on its continuous private offering of unregistered shares totaling $2.5 billion in cumulative consideration.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 7.01
Biohaven disclosed new clinical data in epilepsy with opakalim and positive clinical biomarker/patient data via press releases and an R&D Day presentation on May 26-27, 2026. While clinical trial results can be material to investors evaluating pipeline progress and commercial prospects, this disclosure does not fit the standard taxonomy categories (not an earnings release, not a formal restatement, not an impairment). The material nature of clinical data warrants classification as other_material rather than a routine disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-27
Item 7.01
The disclosure announces investor conference participation and reaffirms 2026 non-GAAP earnings guidance of $3.68–$3.83 per diluted share. While guidance reaffirmation is material to investors, it does not fit cleanly into the standard taxonomy (not a new earnings release, not a guidance miss or material change). The Item 7.01 Regulation FD disclosure is primarily administrative notification of conference attendance, but the guidance reaffirmation elevates materiality.
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-05-26
Item 1.01
NL Industries completed a reincorporation merger on May 26, 2026, changing its state of incorporation from New Jersey to Delaware through a merger of the Predecessor Corporation into its wholly-owned subsidiary NLI Holdings, Inc. The merger involved automatic 1:1 stock conversion and adoption of new Delaware Certificate of Incorporation and Bylaws, with no change in business operations, management, facilities, assets, liabilities, or net worth. Existing directors and officers automatically transitioned to the new entity on identical terms, and stockholder rights were materially modified through changes in governing law, though the company elected not to be governed by Delaware's anti-takeover provisions under Section 203.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 8.01
PNC completed a public offering of $1.65 billion in senior notes ($1.35 billion fixed/floating rate and $300 million floating rate, both due October 2029). While debt issuances are material financing events affecting the registrant's capital structure and liquidity, this disclosure does not fit neatly into the standard 8-K taxonomy—it is neither a restatement, auditor change, going concern, impairment, delisting risk, bankruptcy, covenant breach, cybersecurity incident, nor dilutive equity issuance. The Item 8.01 classification and the nature of the transaction (completed debt offering under an existing registration statement) suggest this is a material financing event best captured as "other_material."
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-26
Item 8.01
Florida Power & Light sold $255.4 million in floating-rate debt securities on May 26, 2026. While this is a material financing event affecting the company's capital structure and future interest obligations, it does not fit cleanly into the standard 8-K taxonomy. The sale is not a dilutive equity issuance (dilutive_issuance applies to equity), not an M&A transaction (ma_activity), and not a covenant breach or going-concern disclosure. As a significant debt issuance by a utility, it is material to investors but lacks a dedicated event category.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-26
Item 8.01
Following the Annual Meeting, John F. Glick was reappointed as Chair of the Board, and three Board committees were reconstituted. These governance actions affect board structure and oversight responsibilities.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-26
Item 8.01
UGI announced early tender results for a $175 million cash tender offer of its 2028 Notes, with $224.8 million tendered (45.6% of outstanding notes) as of the early deadline and pro-rata acceptance at 77.9%, representing material debt management activity affecting the company's capital structure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-26
Item 8.01
The Board of Directors approved a three-for-two stock split, which is a material capital structure change affecting all shareholders' ownership percentages and share count. While stock splits are routine corporate actions, they are material to investors as they affect share price, trading liquidity, and ownership calculations. This does not fit the dilutive_issuance category (which concerns new equity issuance) but represents a significant corporate action disclosed under Item 8.01.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-26
Item 1.01
Aspira entered into a Master Collaboration and License Agreement with Cleveland Clinic Foundation for biomedical research and development, with a $125,000 partnering fee over five years. While this is a material definitive agreement disclosed under Item 1.01, it does not constitute a traditional M&A transaction (no acquisition, merger, or change of control), and the collaboration arrangement with fixed fees and research focus does not fit the more specific event categories. The agreement is material to investors as it represents a significant strategic partnership and commitment of capital.
View raw filing on EDGAR →